Revance Therapeutics

company

About

Revance Therapeutics develops and commercializes products and treatments for dermatological diseases.

  • 101 - 250

Details

Last Funding Type
Debt Financing
Last Funding Money Raised
$8M
Industries
Biotechnology,Health Care,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2002
Number Of Employee
101 - 250
Operating Status
Active

Revance Therapeutics is a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$8M
Revance Therapeutics has raised a total of $8M in funding over 2 rounds. Their latest funding was raised on Nov 18, 2008 from a Debt Financing round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 18, 2008 Debt Financing $8M 1 Detail

Investors

Number of Lead Investors
Number of Investors
1
Revance Therapeutics is funded by 1 investors. Horizon Technology Finance are the most recent investors.
Investor Name Lead Investor Funding Round
Horizon Technology Finance Debt Financing